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Abstract
Background: As thousands of healthy research participants are being included in small and large imaging studies,
it is essential that dilemmas raised by the detection of incidental findings are adequately handled. Current ethical
guidance indicates that pathways for dealing with incidental findings should be in place, but does not specify what
such pathways should look like. Building on an interview study of researchers’ practices and perspectives, we
identified key considerations for the set-up of pathways for the detection, management and communication of
incidental findings in imaging research.
Methods: We conducted an interview study with a purposive sample of researchers (n = 20) at research facilities
across the Netherlands. Based on a qualitative analysis of these interviews and on existing guidelines found in
the literature, we developed a prototype ethical framework, which was critically assessed and fine-tuned during
a two-day international expert meeting with bioethicists and representatives from large population-based imaging
studies from the United Kingdom, Germany, Sweden and Belgium (n = 14).
Results: Practices and policies for the handling of incidental findings vary strongly across the Netherlands, ranging
from no review of research scans and limited feedback to research participants, to routine review of scans and the
arrangement of clinical follow-up. Respondents felt that researchers do not have a duty to actively look for incidental
findings, but they do have a duty to act on findings, when detected. The principle of reciprocity featured prominently
in our interviews and expert meeting.
Conclusion: We present an ethical framework that may guide researchers and research ethics committees in the design
and/or evaluation of appropriate pathways for the handling of incidental findings in imaging studies. The framework
consists of seven steps: anticipation of findings, information provision and informed consent, scan acquisition, review of
scans, consultation on detected abnormalities, communication of the finding, and further clinical management
and follow-up of the research participant. Each of these steps represents a key decision to be made by researchers,
which should be justified not only with reference to costs and/or logistical considerations, but also with reference to
researchers’ moral obligations and the principle of reciprocity.
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Background
Research groups worldwide are studying the human
body making use of non-invasive imaging techniques,
notably magnetic resonance imaging (MRI). On MR im-
ages, researchers will incidentally come across so-called
incidental findings, findings that are beyond the aims of
the study but may be of potential health or reproductive
relevance to - otherwise healthy - research participants
[1]. Detection and feedback of incidental findings are a
double edged sword: they may allow for timely treatment
and thus lead to medical benefit, but may also harm re-
search participants because of the risks, psychological
burdens and costs of follow-up testing and (over)treatment
[2, 3]. Not all abnormalities warrant clinical follow-up,
[4–6] or lead to the possibility of procuring health bene-
fits [4]. Thus, incidental findings tend to place researchers
before an ethical dilemma: to actively search for these or
not, and to refer for further work-up or to remain silent.
The prevalence of clinically significant incidental find-
ings among healthy participants is estimated around 2.7%
in brain MRI, with a number needed to scan of around 37
for one finding deemed of clinical significance [7]. Though
the prevalence of incidental findings may be lower in
children and adolescents than in the elderly, they are
not extremely rare in the young [8, 9]. In imaging of
other body parts (e.g. abdomen or whole-body), the fre-
quency with which incidental findings are detected may
be much higher [10, 11]. In Europe, large population-
based cohort studies are currently underway, in which
(tens of ) thousands of healthy research participants are
undergoing imaging of the body or brain – in the case
of UK Biobank, even a hundred thousand [10, 12–16].
Large numbers of incidental findings can thus be ex-
pected in the next few years.
International guidelines for the detection, management
and feedback of incidental findings in the context of
research have, as of yet, been largely procedural and quite
non-specific, and have allowed for a “range of options” [17]
or a “spectrum of models” [18] to evolve for the handling
of incidental findings [19, 20]. For instance, whereas in
some studies, research scans are checked for image quality
only and very limited feedback is given to research partici-
pants, [13] other groups conduct a full clinical review of all
research scans by expert radiologists [10]. Practices for
the handling of incidental findings thus vary considerably
across studies and research settings [20, 21].
Although current guidelines are non-specific in how
incidental findings should be handled, they do agree on
some important points. When abnormalities of potential
clinical significance are being picked up by researchers,
they should act [1, 19, 22, 23]. Further, researchers ought
to consult with an expert (usually a radiologist) to confirm
the imaging finding before informing the research partici-
pant [20, 24]. Moreover, a predesigned pathway for the
handling of incidental findings, including expert consult-
ation, should be in place and should be communicated
beforehand with research participants, preferably as part
of the informed consent process [1, 19, 22, 25]. Finally, the
pathway should ideally be reviewed by an ethics commit-
tee or institutional review board [26]. However, as general
ethical frameworks are still lacking, [25] ethics committees
may currently be insufficiently equipped to evaluate
pathways for the handling of incidental findings within
research protocols.
With the rise of the use of imaging techniques in
research comes an urgent need for practical ethical guid-
ance. Researchers need to know what adequate pathways
for the handling of incidental findings look like. In this
paper, we present a seven steps framework to be used by
researchers and/or ethics review committees when setting
up or evaluating pathways for the handling of incidental
findings in imaging studies. Researchers will need to con-
sider each of the seven steps of the framework, will need
to decide how to give them shape in a pathway for the
handling of incidental findings, and will need to justify
these decisions, taking research participants’ moral expec-
tations into account. The seven-step framework has been
developed based on an interview study and an expert
meeting on current practices for the handling of incidental
findings.
Methods
This paper explores current practices for the detection,
management and communication of incidental findings
in neuroimaging and other research centres in the
Netherlands, as well as - senior and junior - researchers’
perspectives on their moral obligations with regard to inci-
dental findings. The approach taken consists of two compo-
nents: an interview study and an expert meeting.
As part of an extensive qualitative research project of
stakeholders’ perspectives on incidental findings, we con-
ducted semi-structured individual and group interviews
with researchers, researchers-radiologists, and research
managers involved in imaging studies or biobanking at
seven Dutch research centres or academic institutions
(total n = 20), including both hospital-based or hospital-
affiliated research centres and dedicated neuroscience
research centres. Respondents were involved in brain
imaging (MRI) for various research aims, medical and
non-medical, either as stand-alone imaging studies or
as part of wider sets of tests and examinations within
larger studies. PhD-students from various institutions
were also interviewed to compare daily practice with
institutional policies. Further, general practitioners who
are involved in imaging studies, a medical psychologist,
directors of screening programmes and a director of a
biobank (see Table 1), about their views on and experiences
with incidental findings. All respondents were interviewed
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at their work locations in various regions across the
Netherlands. At two research centres (both population-
based cohort studies), the researchers (LvB and EB)
were invited to observe the scan acquisition processes,
and conducted informal interviews with research assistants
and radiographers. Also at 4 centres (two population-based
cohort studies, neuroimaging centre A, hospital-based im-
aging centre), respondents made available participant infor-
mation sheets, informed consent forms, and/or internal
documents outlining policies for the handling of incidental
findings to the researchers. At other centres, respondents
did not demonstrate the research process or make available
additional materials to the researchers. Interviews lasted
between 60-90 minutes, and were carried out by one (LvB)
or two (LvB and EB) researchers between March and May
2014. Respondents were asked to explain their institutional
pathways for the handling of incidental findings, to
identify ethical issues, and to elaborate on their views
on researchers’ moral obligations with regard to inci-
dental findings.
The interviews were digitally recorded, transcribed
verbatim and stored securely. Emotional responses (e.g.
‘sigh’ or ‘silence’) were also noted by the interviewer(s).
This was done as deemed relevant by the interviewer, not
done in any systematic way. Paper-based and basic word
processing methods were used for data analysis. Interview
transcripts were coded independently by two researchers
(LvB and EB) using a constant comparative method, [27]
which entails going back and forth between transcripts
and codes and themes in an ongoing, iterative process
[28]. Codes were assigned, regrouped into higher-order
themes, and refined through multiple readings and re-
readings. Discrepancies were resolved through discus-
sion. Main themes were identified, and were used to
collect and regroup transcript fragments.
Based on the results of our interview study, we have
drawn up an ethical framework for the detection, man-
agement and communication of incidental findings de-
tected through imaging in research, consisting of seven
points that should be considered prior to the start of
every imaging study (see Discussion). This framework
was presented and corroborated at a 2-day international
expert meeting, organised at the Department of Medical
Ethics and Philosophy of Medicine in Rotterdam in
2015, in which representatives were gathered from large
European population-based cohort studies as well as from
various research centres in the Netherlands. The attending
experts (n = 14) came from the Netherlands, the United
Kingdom, Germany, Sweden and Belgium. Apart from
(neuro)radiologists and (neuro)science researchers, the
group also involved ethical and legal experts. Some
attendants were not involved in large population-based
studies, but in neuroscience or genomics studies. The
main aims of the expert meeting were to share best
Table 1 Respondents included in the interview study
Respondent (Bio)medical discipline Position Type of research centre
1 Neuroradiology PI Population-based cohort study A
2 Neuroradiology PhD-student Population-based cohort study A
3 Neuroradiology PI Population-based cohort study B
4 Neuroradiology PI Neuroimaging centre A
5 Neuroscience PhD-student Neuroimaging centre A
6 Neuroscience PhD-student Neuroimaging centre A
7 General medicine PhD-student Hospital-based imaging centre
8 Psychiatry PhD-student Hospital-based imaging centre
9 Neuroscience PI Neuroimaing centre B
10 N.A. Research manager Neuromaging centre B
11 General medicine PhD-student Neuroimaging centre B
12 Neuroscience Research assistant Neuroimaging centre B
13 Radiology Director National screening programme A
14 N.A. Director National screening programme B
15 N.A. Legal advisor National screening programme B
16 General medicine Medical advisor National screening programme B
17 Pathology Director Biobank at academic hospital
18 Medical psychology Psychologist Academic hospital
19 Primary care General practitioner Private practice
20 Primary care General practitioner Private practice
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practices and moral considerations, and to discuss our
ethical framework for the handling of incidental findings in
research. Based on the expert meeting, we fine-tuned, com-
plemented and adjusted our framework. The outcomes of
the expert meeting will be presented in the discussion.
Results
First, we give an impression of the range of pathways that
currently exist in the Netherlands for the handling of inci-
dental findings. Then we outline how and why our respon-
dents made choices about the set-up of their adopted
pathways. Finally, we report on our respondents’ views on
researchers’ moral obligations.
Pathways and policies for the handling of incidental
findings differ across the Netherlands
Pathways and policies for the detection, management
and communication of incidental findings were variable:
some centres had detailed pathways in place, outlining
what to do and whom to contact in case abnormalities
were detected, while other centres were still in the
process of setting up policies or pathways for the handling
of incidental findings, or were struggling with incidental
findings on a case-by-case basis. While most respondents
supported policies that ensured that potentially relevant in-
cidental findings are reported back to research participants,
others maintained limited or ‘no feedback’ policies. In four
centres, internal documents described standard operating
procedures researchers or radiographers were expected
to follow when confronted with abnormalities. While
these procedures were largely similar (e.g. scans should
be saved in specific ways and on specific locations, a
person centrally handling incidental findings should be
contacted, the researcher should wait for a confirma-
tory response from a (neuro)radiologist), there were
also differences with regard to whether or not researchers
or radiographers were required to make additional
diagnostic-quality scans of potentially abnormal brains,
and whether or not they were allowed to inform the re-
search participant about the finding during the scan-
ning process.
Moreover, young researchers or radiographers were
given different, sometimes conflicting instructions: in
some centres, researchers were actively discouraged
from ‘looking for’ abnormalities on scans, while in
other centres, researchers were trained ‘how to check’
for incidental findings. These differences are illus-
trated by the following fragments from a group inter-
view with three PhD-students working at two imaging
centres in the same city:
PhD-student a: You’re not really going to look for things,
right? […] But if you really see something, you report
that. That’s what the protocol says.
PhD-student b: But isn’t there a hospital-broad protocol
that says: ok, this is how you check for incidental
findings?
PhD-student c: No, you don’t really have to check, right?
It is an incidental finding when you come across
something.
PhD-student a: No, that’s right, there is no need to
check. But if you see something, you report. That’s the
protocol. But it’s not like everyone will look at scans in
the same way or search for things…
PhD-student c: I think it’s right not to look for things.
Policies with regard to the feedback of imaging results
to research participants varied, as well. In some centres,
researchers were instructed to refrain from providing
any information to research participants, while in other
centres, researchers were encouraged to offer research
participants their scans on CD.
PhD-student a: So you make a screenshot?
PhD-student c: Only if [participants] ask. We don’t
routinely offer it to them.
PhD-student b: You don’t routinely offer it to them? We
always just give it to them.
PhD-student c: What? A screenshot or a CD?
PhD-student b: A CD with everything […]
PhD-student a: So you have all the images to scroll
through?
PhD-student b: Yes […] Does your centre really advise
against that?
PhD-student c: Definitely. I am told not to even show
the computer screen to participants […]
PhD-student b: They really like it […] Especially since it
is about their own brain […] One participant had even
printed an image on his T-shirt!
(PhD-students a and c (respondents 7 and 8) work at a
hospital-based imaging centre, PhD-student b (respondent
5) works at an independently located neuroimaging centre.)
Pathways: seven steps
After learning from all of our respondents about various
existing pathways for the detection, management and
communication of incidental findings used in several
research centres across the Netherlands, we identified
seven crucial steps in these pathways: anticipation of
findings, information provision and informed consent,
scan acquisition, review of scans, consultation on detected
abnormalities, communication of the finding, and further
clinical management and follow-up of the research partici-
pant. Together these seven steps form an ethical frame-
work for the handling of incidental findings. Below, the
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findings from our interview study will be presented along
the lines of this seven step framework. In each of these
seven steps, researchers have to make choices with regard
to the pathway for the handling of incidental findings, and
have to justify these choices. These choices and their
justifications were the topic of many of our discussions
with respondents.
Anticipation of incidental findings
Not all research centres have prepared for the occurrence
of incidental findings to the same extent. This may be
because incidental findings tend to occur more frequently
in clinical or population-based cohort studies than in
neuroscience, cognitive science or behavioural science
studies, and are perceived to pose more of a problem in
the former than in the latter:
We’ve been here for twelve years by now, we have
[acquired brain scans from] 3,000 people annually.
There have been [a few] incidental findings, but no one
has died from them. […] The panicky idea that we could
be saving lives by detecting incidental findings, I am not
buying that. (research manager at neuroimaging centre
b, respondent 10)
So there is a big problem, I can tell you that. As a
doctor you cannot lay awake at night […] But no
one should deny that this is a big problem.
(neuroradiologist at population-based cohort study
a, respondent 1)
The differences in frequency – and concurrently in
problem perception – may be explained in part by
differences in age ranges of the scanned participants: in
some neuroscience centres, research participants are
typically young students seeking to acquire university
credits or to earn some extra money. Few clinically relevant
incidental findings seem to be detected in healthy young
volunteers:
Really, we’re talking about one case in five years, or
something. […] That is what the fuss is all about.
Everyone is really focused on this. It is different with
the elderly. Maybe you should [discuss incidental
findings] with the elderly, but not with the young.
(principal investigator (PI) at neuroimaging centre a,
respondent 4)
Some centres, in which incidental findings occur with
a relatively high frequency, have explicit protocols in
place for their management. At one centre, an interdiscip-
linary expert panel has assessed the practical and clinical
utility of relatively frequently occurring incidental findings
and compiled a list of findings to report and findings not
to report to research participants. Rare, unexpected inci-
dental findings that have not been anticipated in the
protocol, are discussed during a panel meeting to decide
whether or not to notify the research participant:
We have really made a list that explicates which
findings we report and which findings we intentionally
do not report. And everything in between, everything
else we encounter, we will have to discuss anew.
(neuroradiologist population-based cohort study b,
respondent 3)
At other centres, where policies have not been written
down, respondents did have a sense of the criteria that
are used, implicitly or explicitly, in discussions about
what incidental findings to report and what findings not
to report. Respondents mentioned criteria such as a serious
or life-threatening disease, treatability or ‘actionability’
(clinical utility), or whether informed consent was given
to learn about incidental findings:
I always just stick to this, together with the rest of the
[hospital], that it should be life-threatening and treatable
before you are going to burden someone with [an
incidental finding]. (director of a biobank, respondent 17)
Information and informed consent
Many respondents felt it is important to inform research
participants beforehand about the possibility that inci-
dental findings may be detected during research. Some
respondents however felt no need to explicitly discuss
the issue of incidental findings beforehand, as they occur
only rarely or have little clinical importance. Further, re-
searchers worried that information about incidental find-
ings would cause (needless) anxiety or apprehension in
research participants, so that they may no longer be will-
ing to participate in research:
Incidental findings are of such little relevance that you
don’t even need to discuss them with subjects. You don’t
even need to talk about incidental findings in the
informed consent. Because they have no consequences in
the young. (PI at neuroimaging centre a, respondent 4)
I am wondering whether [pre-scan information on
incidental findings] may cause more harm than good,
because you may deter [research participants] more, so
that they may no longer be willing to participate. And
they may overestimate the chance that something will
be found. (PhD-student a at neuroimaging centre b,
respondent 11)
At most centres, however, researchers are obliged by
internal policies to inform research participants that
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incidental findings may be detected. As part of the in-
formed consent, research participants will have to agree to
receiving feedback about any clinically relevant incidental
finding. Often, participants will also have to agree to the
researchers notifying their primary care physician in case
an abnormality is detected.
During the informed consent process, research partici-
pants are often told that research scans are not diagnostic
scans, that research scans will not be reviewed by medical
doctors, that incidental findings are rare, and that not
hearing back from the researcher does not signify that the
research participant is healthy or free from abnormalities.
Some respondents felt uncertain whether research partici-
pants understand the information provided, or felt that
the information itself is ambiguous:
Look, you can say: ‘This is scientific research, no
medical doctor is going to be looking at [these scans],
no clinical eye, there is no such thing as gaining
medical benefit from this’. But then you’re also saying:
‘If we do find something very odd, we will tell you.’
Well, then you’re dithering: we’re not looking, but we’re
looking. This is an ambivalent message, if you ask me.
(primary care physician a, respondent 19)
Well, I think it is important to explain [that you are
not looking] to research participants, but I do think
that people will think, in the back of their minds: ‘Oh,
but if there really is something wrong, those
[researchers] will see that, and then they will send
[the scan] on [to an expert radiologist]. I do think
that [scanning] offers false reassurance. (PhD student at
a hospital-based imaging centre, respondent 8)
Despite serious attempts to downplay participants’
expectations with regard to clinical review during the
informed consent process, respondents felt that many
research participants continue to assume that apparent
abnormalities will be detected and acted upon by
researchers.
Scan acquisition
Typically, in clinical or population-based cohort studies,
the sequences acquired (T2 weighted or fluid-attenuated
inversion recovery (FLAIR) images) are of higher diagnostic
utility than the sequences acquired (T1 weighted or
functional MR images) in more fundamental research,
e.g. neuroscience studies. Diagnostic-quality images will
generally lead to the detection of more incidental find-
ings than functional MR images. But even in research
centres that are not hospital-based, in which only functional
MR images are acquired in the context of studies that have
non-medical aims, the possibility of detecting abnormalities
is often brought up by volunteers. Sometimes, researchers
are psychology or neuroscience PhD-students with limited
medical background and may not be able to confidently
answer volunteers’ questions:
It is an often recurring issue, in discussions with
participants, too. […] They will always be asking:
‘Well? Does everything look normal?’ (PhD-student at
neuroimaging centre a, respondent 6)
At other research centres, radiographers are operating
the MRI scanner, and researchers will not have direct
contact with research participants. Both radiographers
and PhD-students seem well aware that they are not in a
position to offer medical/clinical feedback to research
participants during or following a scan. Respondents felt
that radiographers or researchers are under no (formal) ob-
ligation to check for abnormalities during scan acquisition:
The researchers perform the scanning themselves. They
will have to become certified users, but that has only
to do with technical skills and not with the assessment
of the brain at an anatomic level. So these are not
people who know what a brain looks like. So they
either detect something by coincidence or they don’t.
There is no obligation on the part of the researcher to
scroll through every anatomical scan, slice by slice, to
see is there is something wrong. (PI at neuroimaging
centre b, respondent 9)
Some researchers feel that they should (briefly) check
research scans for abnormalities anyway, while operating
the scanner, whereas others do not. Research scans are
thus ‘looked at’ differently by different researchers.
Review of scans
The extent to which research centres review brain scans
varies. Some centres ask researchers or radiographers to
assess the quality of the scan only, on the spot, during
scan acquisition: have the required sequences been made,
are all required measurements or biomarkers present and
clearly visible? In those centres, no arrangements have been
made for the review of research scans for abnormalities,
and PIs may tell junior researchers or radiographers that
the detection of incidental findings is something to be
avoided. These are usually centres in which only functional
imaging sequences with limited structural sequences (only
T1-weighted) are acquired, the diagnostic utility of which is
limited. Such images do not easily allow for the adequate
detection or clinical interpretation of certain incidental
findings, such as aneurysms, although large tumours may
be spotted.
Other centres have set up a system in which all
diagnostic-quality research scans are reviewed for
abnormalities, either directly by an expert neuroradiologist
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or indirectly, after possible incidental findings have been
flagged by research personnel. One centre especially trains
their PhD-students (most of them have a medical back-
ground and are training to become radiologists), through a
training programme that was developed in-house, to distin-
guish normal brains from abnormal brains. When the PhD-
students detect an abnormality, they put it on the agenda
of a two-weekly team discussion, led by an expert neurora-
diologist. The expert neuroradiologist will explain the ab-
normality to the researchers and decide whether or not to
report the finding to the research participant.
One respondent from another centre in which routine
clinical review of all research scans is meant to be con-
ducted, explains that the centre lacks the manpower and
the financial means to review scans in a timely manner.
The respondent is not comfortable with this situation, as it
entails that research participants will need to be notified of
an incidental finding a long time after the scan was
acquired. Research participants may not understand or
appreciate the time lag, especially when children are in-
volved as research subjects:
This is a seven-year-old child. The scans had not been
reviewed before. Because, well, that is because of a
backlog in reviewing. Because, you know, it is a lot of
work. And it is work that is unpaid. No reimbursement.
A year later we are analysing these images for a scientific
research question, and the researcher is saying: ‘Hey,
something is wrong here’. We’re seeing this asymmetry
[possibly a tumour]. (neuroradiologist at population-
based cohort study a, respondent 1)
Consultation on detected abnormalities
Many centres instruct researchers that when they do
detect an abnormality, they must contact the principle
investigator or manager of the research centre. The PI
or the manager may not be an expert (neuro)radiologist
him- or herself, but he or she is in a position to decide
whether or not consultation by an expert will be neces-
sary. It is generally agreed upon that incidental findings
should be confirmed by an expert (usually a radiologist)
before the research participant is informed.
One respondent was concerned with the potential
harms and burdens of asking for expert opinion. This
respondent felt that as research participants are presumed
healthy and free of symptoms, incidental findings will –
almost by definition – have limited clinical significance
and will not affect the participant’s daily life in any way.
Incidental findings, in this respondent’s opinion, will not
lead to medical benefit, and may only cause harm:
With [referring the research participant for expert
consultation] you will needlessly trouble the research
participant. If it may not affect the participant’s daily
life, you will have to ask yourself: are you really going
to start an entire procedure, in which you’re asking the
neurologist and the primary care physician for their
opinion? This will only upset the research participant,
often for no reason. (primary care physician b,
respondent 20)
It can be difficult to find expert (neuro)radiologists
who are willing to assess incidental findings on a case-
by-case basis, even if they were to be reimbursed. One
respondent from a neuroimaging centre indicated this.
Radiologists, our respondent thought, are hesitant to
take on the liability of reviewing research scans, and fear
that they would miss something:
Well, we choose not to have radiologists [routinely]
look at scans. That is too expensive. We don’t do that.
So it becomes an incidental finding. […] Then you
need someone [an expert radiologist] who can assess
whether it is [an abnormality that needs reporting] or
not. Well, you go and try to find such a person. (research
manager at neuroimaging centre b, respondent 10)
Communication of the incidental finding
Respondents felt that the communication of an incidental
finding should be undertaken by medical doctors. Re-
searchers who are not doctors, some of our respondents
said, cannot legally enter into a physician-patient relation-
ship, in which a diagnosis can be conveyed or recommen-
dations for tests or treatments can be given. Research
centres will thus rely on in-house medical doctors to tell
the participant about the incidental finding, or need to
refer the participant to an external doctor for the feedback
of the finding. One respondent said that for his centre, it
is not practically or financially feasible to hire doctors to
communicate findings. Therefore, this centre will not
provide feedback on any findings at all.
We cannot afford feeding back this information. […]
I cannot do it myself […] because I am not medically
trained. […] So a physician would have to be arranged
to feed the information back. And for those reasons we
have decided: we’re not going to do it. (director of a
biobank, respondent 17)
Some respondents feel that incidental findings should
be communicated via primary care physicians. It is an
internal policy in many research centres that researchers
contact the participant’s primary care physician after the
finding has been confirmed. Informed consent forms usu-
ally contain the name and contact details of participants’
primary care physicians. Researchers will send a letter to
the primary care physician, explaining the finding and
include the expert report. The primary care physician, it is
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thought, will be able to contextualise the finding and
decide whether or not to tell the research participant:
I strongly support that [IFs are reported through
primary care physicians]. The primary care physician
knows the social situation of the patient, knows the
co-morbidity, has a better understanding of [the patient…]
I think the primary care physician is the right person. Just
to take the context into account when communicating
with the patient, but also for the follow-up. (primary
care physician a, respondent 19)
One respondent disagreed. Research participants may
feel bypassed when researchers would contact their primary
care physicians without them knowing. As a researcher and
medical doctor, this respondent usually contacts research
participants directly, from the research centre, over the
phone, to tell them about an incidental finding and to refer
them to a clinical specialist (i.e. neurologist, neurosurgeon):
We offer participants the chance to choose against
acting upon an incidental finding. So that we do not
send them into the medical ‘circus’ against their wishes.
So we always ask the question [whether or not they
want to follow up on the finding]. We do not seek
contact with the primary care physician before talking
to the participant him- or herself, because that feels
like sharing private information behind someone’s
back. The participant him- or herself should control
that information. So on the phone I always ask: ‘Now,
I have told you this, and probably your primary care
physician would like to know about this, too. Are you
OK with that?’ (neuroradiologist at population-based
cohort study b, respondent 3)
In practice, very few research participants keep the
researcher from letting their primary care physician know
about the finding.
Further clinical management and follow-up
In some cases, hospital-based or hospital-affiliated re-
spondents have made prior arrangements or maintain
relationships with clinical specialists, so that whenever
they notify a research participant about an incidental
finding, an appointment with a clinical specialist can be
arranged within a timeframe of a couple of days. This
approach, it is thought, will reduce uncertainty and
anxiety in research participants. Other respondents in-
dicated that they simply refer research participants to
their primary care physicians, who may then arrange a
meeting with a clinical specialist for them, if deemed
necessary.
Because researchers are not in a physician-patient rela-
tionship with their research participants, they rarely hear
back from them, and often do not know what happens
to research participants after they have been told about
incidental findings.
What I have heard […] is that it all went well and
that, given the circumstances, the information [about
the incidental finding] has been received well. So that
is what we hear back. But because we are not in the
role of the physician, we don’t get to hear any details.
So you will just have to assume that it went well.
(director of screening programme a, respondent 13)
We have had that question from the ethics review
committee: ‘Can you not follow up on these research
participants?’ But when they are in the care of a
physician, [the physician] will have his professional
confidentiality, and we are not medical doctors. We
are not a medical centre, so a doctor can tell us
nothing, unless the research participant indicates that
he wants his doctor to inform us, but the research
participant will have other things on his mind. (PI
at neuroimaging centre b, respondent 9)
One respondent did follow up on incidental findings as
part of a research protocol, and gathered information from
medical specialists on the tests and treatments offered to
research participants. This information was used to adapt
the protocol for the handling of incidental findings:
At one point we had referred thirty people or so to the
endocrinologist [for small pituitary cysts]. And then
there were hormone examinations and new scans.
After that we drew up the balance sheet and it turned
out that none of these thirty people were suffering from
hormone disorders. […] So we decided in a team
conference that it was probably not that useful to refer
people with such an abnormality. (neuroradiologist at
population-based cohort study b, respondent 3)
Moral responsibilities
During our interviews, we sought to elucidate researchers’,
research managers’ and other stakeholders’ views of the
moral responsibilities of researchers. Do they think re-
searchers are morally required to ‘look for’ incidental find-
ings? Do they think they are to be blamed when they ‘miss’
incidental findings? What are researchers’ moral consider-
ations regarding the detection, management and communi-
cation of incidental findings? What do they perceive to be
their (implicit) mission statements as researchers?
Researchers’ responsibilities to look for incidental findings
Many of our respondents did not consider it a researcher’s
responsibility to actively look for incidental findings. Re-
searchers should focus on conducting research and need
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not employ a ‘clinical eye’ when looking at images or other
research data. Correspondingly, there is no such thing as a
moral or legal liability for failing to notice or missing an
incidental finding:
You have to think about what the responsibilities are
of someone who is holding the materials and looking
at the results of those tests. This [researcher] is not
trained to find such things. So if he is alert, he’ll
notice, but you can’t blame him if he’s not alert.
(director of a biobank, respondent 17)
Several researchers remembered cases in which the
research centre had been approached by research par-
ticipants or their family members, when they fell ill.
Researcher participants or their family members had
demanded clarification: Had the condition not been
visible on the research scan that was made at the centre a
few months before? Sometimes the researchers had to
admit that the abnormality was indeed visible on the scan,
but had not been noticed by the researchers. At other
times the researchers concluded that the abnormality had
not been present at the time of the research scans. Either
way, although such cases seemed to have made an emo-
tional impression on researchers, most did not think they
were culpable.
This woman [whose mother recently died] came to the
clinic to see the neurosurgeon and tells the neurosurgeon:
‘My mother participated in a scan study 8 months ago.
Have they not seen anything?’ So the neurosurgeon calls
the researcher and asks: ‘Have you not seen the tumour?’
So we go and look at the scans […] Here you see a small
aberration. These images had been reviewed. [The
aberration was] not detected. So we have to tell this
patient: ‘Yes, we checked the images again, and in
retrospect we can see something. […] Yes, we can see it
now, but we missed it then […] And now she died.
(neuroradiologist at population-based cohort study a,
respondent 1)
We call it the retroscope: when you know where
something has been found, when you look back exactly
in that place, you increase your sensitivity to find
something there. Then we said: if we’re looking at both
scans, we can now see that something was amiss on
that first scan, but if we had only the first scan […] we
couldn’t have seen it then. It is not like we missed
something. (neuroradiologist at population-based
cohort study b, respondent 3)
Researchers’ responsibilities to report incidental findings
The respondents thought that it would be wrong not to
tell research participants about clinically relevant incidental
findings, when detected. Some incidental findings may not
cause symptoms now, but they may start to do so in the
future. When research participants and their doctors have
been told about the finding, they may be spared unneces-
sary diagnostic delays, and the burdens and costs associated
with such delays.
You cannot do that: keeping things from people. Not
the things which are relevant enough to report to a
primary care physician. (primary care physician b,
respondent 20)
Think about this: at a certain point in time this
person develops a headache or something, and we all
know how long it takes for a patient to go through the
medical parade before [doctors] order a brain scan,
and it turns out to be a cyst. And we would have
known all along [that it was a cyst…] I do understand
that you shouldn’t worry people unnecessarily, but on
the other hand I do think it would be strange to
withhold this information from a research participant.
(neuroradiologist at population-based cohort study a,
respondent 1)
One respondent disagreed, and felt that researchers
have a responsibility to decide carefully whether or not
it will benefit the research participant to receive infor-
mation about the incidental finding. In many cases, inci-
dental findings will prove of limited clinical utility, this
respondent thought, and will only harm research partici-
pants. The researcher should thus decide not to tell the
research participant:
The moral obligation, I think, is also to build some
form of protection against those five dots on the MRI
that mean nothing but could haunt people for the rest
of their lives. (director of a biobank, respondent 17)
Researchers’ care obligations
Respondents were well aware of the differences between
the legal and moral obligations of physicians caring for
patients on the one hand, and researchers conducting re-
search with the help of research participants on the other
hand. Still, researchers felt that there are special moral obli-
gations that flow from the researcher-research participant
relationship. Researchers cannot treat research participants
like instruments or models, but show - or should show –
concern for research participants.
I believe [it has to do with] integrity. Like: this is how
we deal with our research participants. We’re not just
hauling them in and out of our scanners, and that’s
it, you get paid or you get [university] credits [in case
of students]. We take a broader perspective. This is
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not about care per se, but it is about, well, concern.
We’re not in a care relationship – these are not
patients. They are research participants, for whom
you do take responsibility. (PI at neuroimaging centre
a, respondent 4)
One respondent felt that researchers, like doctors,
are responsible for the health of their participant.
Research participants expect researchers to care for
them. This may apply even more to researchers who
are also physicians.
[Research participants] expect you to feel responsible.
You can try to demarcate and say: ‘Well, this is
research, we are only looking at the science, we’re not
looking after your health, but that is not how life
works. People expect you to [look after their health].
There are expectations. (neuroradiologist at
population-based cohort study a, respondent 1)
The principle of reciprocity
The concept of expectations was often brought up during
our interviews. Some of our respondents felt that they
were expected to look after research participants’ health,
to look carefully at research data, to check whether ‘every-
thing looks normal’. To these respondents it seemed that
one of the main motivations for volunteers to participate
in studies is to receive a ‘health check’. These respondents
mentioned the principle of reciprocity, which would sug-
gest that research participants’ expectations (i.e. the health
check) should be met, and that indeed, researchers should
check images for abnormalities.
I think it’s good [if researchers feed results back],
because [research participants] value that. I think
it’s a type of exchange: you participate and you want
an answer, then you shall naturally have that
answer. [It is] a social interaction. (neuroradiologist
at population-based cohort a, respondent 1)
We know that most people participate because they
see this as a [free medical] check-up. (primary care
physician a, respondent 19)
And you notice […] that many people participate in
research, secretly with the idea that they will learn
about serious abnormalities in the brain. (PI at
neuroimaging centre b, respondent 9)
Other respondents chose to clearly inform research
participants beforehand that the imaging study does not
function as a health check, and will not lead to medical
benefit for participants.
Discussion
Existent ethical and legal guidance, so far, has suggested
that a pathway for handling incidental findings should
be in place at the outset of the research program, evaluated
by an ethics committee and communicated to research par-
ticipants as part of the informed consent process [1, 26].
However, no specific criteria have been established for the
setting up of such a pathway or for the evaluation of path-
ways within study protocols. Is there really nothing
more to say – normatively – about pathways for hand-
ling incidental findings, over and above that they
should be present and should be evaluated on a case-
by-case basis? Based on our interview study and ex-
pert meeting, we contend that there is: any responsible
pathway in a high-income country must, at minimum,
adequately address the seven steps listed in our frame-
work. It should be noted that, as this study was con-
ducted in the Netherlands, the outcomes and the
resulting ethical framework cannot be translated dir-
ectly to other countries, such as low and middle-
income countries.
The seven steps of the framework need not and cannot
be addressed in precisely the same manner in all research
studies. Given the reported variability between research set-
tings, it will hardly be possible to converge on a single eth-
ical standard for the design of pathways for the handling of
incidental findings in (brain) imaging research [23, 29].
Highly demanding pathways may not be feasible or de-
sirable across all research settings, e.g. in low-resource
countries. Moreover, in research settings in which only
functional brain imaging is acquired for non-medical
purposes, the chances of detecting interpretable, clinically
relevant incidental findings are slim. It may be unnecessar-
ily burdensome to trouble volunteers with information on
the possibility – however small – of incidental findings and
the implications thereof. Ethical guidance will thus have to
be differentiated [29].
The seven steps framework therefore, cannot serve as
a cookbook, but rather points out a series of decisions
that each research team will have to make and will have
to justify. Decisions should be justified in the light of not
only considerations of feasibility, logistics and cost [23, 25],
but also medical-ethical considerations such as potential
harms and benefits or the principle of beneficence, [18] and
respect for research participants [30]. Researchers and eth-
ics committees will need to balance these considerations on
a case-by-case basis and make trade-offs between the finan-
cial and organizational costs of a pathway and its potential
for medical benefit. However, especially in high-income
countries, a set of minimum requirements should be met
(see Table 2). The costs need not be prohibitive: it has been
found that a ‘universal review and disclosure system’ can
cost as little as 23 US dollars per scan [31]. Even limited po-
tential medical benefit – or the principle of reciprocity -
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might outweigh such costs in high-income countries.
On the other hand, researchers should protect re-
search participants against unnecessary harm [32],
and need not inform them about clinically insignifi-
cant – and potentially harmful - incidental findings.
After all, the reporting of incidental findings can be
in the interest of research participants, but may also
have adverse implications [2].
Our respondents recognised that researchers are
held by special moral responsibilities with regard to
the detection and careful handling of incidental find-
ings. This is consistent with the entrustment model of
the researcher-research participant relationship [33, 34],
which sets out role-specific ancillary care obligations for
researchers. These obligations follow from the informed
consent process, through which research participants
entrust aspects of their health to the researcher. Based on
this ‘partial entrustment’, researchers have a duty of rescue
towards research participants that is stronger than that of
ordinary citizens towards one another [34, 35], and are ex-
pected to care for entrusted aspects of research partici-
pants’ health (e.g. the brain). Researchers would thus have
a strong role-specific moral imperative to act upon clinic-
ally relevant incidental findings detected during imaging.
In addition, the principle of reciprocity featured prom-
inently in our interviews with researchers (and in our in-
terviews and focus groups with research participants,
which will be reported separately), and gained traction
during our expert meeting. Our respondents believed
that an adequate response to incidental findings is an
expression of respect for research volunteers’ contribution
to scientific research. Studies have shown that many re-
search participants expect that incidental findings, if
present, will be detected and will be acted upon [25],
and have a strong preference for receiving information
about incidental findings [36–38]. Based on the principles
of respect for (the autonomy of) research participants and
of reciprocity, researchers may have reasons to check for
abnormalities when they can.
Ethics review committees will have an important part to
play in shaping researchers’ responsibilities, by evaluating
and refining pathways for the handling of incidental find-
ings within research protocols. The seven steps framework
can help guide ethics committees’ deliberations. In addition,
we will now provide some considerations to help determine
the adequacy of researchers’ decisions with regard to the
management of incidental findings. These considerations
reflect current ethical guidance and best practice, and
although such high standards may not be achievable for all
research groups at present, they do set an example.
Furthermore, based on ethical discussions in the litera-
ture, our interview study and expert meeting, we out-
line some minimum requirements for each of the seven
steps (see Table 2).
Table 2 The seven steps framework and minimum requirements for pathways for the detection, management and communication
of incidental findings in research
The seven steps framework Minimum requirements
1. Anticipation of incidental findings Incidental findings should be anticipated.
In large-scale imaging studies, lists should be made of anticipated incidental findings,
stipulating their management.
2. Information provision and informed consent As part of the informed consent process, research participants should be informed about
the possibility that incidental findings
may be detected, and about the pathway for handling such findings.
Research participants should be given the opportunity either to opt out of receiving
information about incidental findings or to withdraw from the study.
3. Scan acquisition Researchers need not acquire any (diagnostic-quality) scans in addition to the scans that
are necessary for the research purposes.
Radiographers should be instructed whether and to what extent to review scans for
abnormalities during scan acquisition
4. Review of scans In studies in which diagnostic-quality images are acquired, some form of routine review of
research scans should be arranged.
5. Consultation on detected abnormalities Detected abnormalities should be confirmed by experts (i.e. radiologists) before they are reported
to the research participants.
Researchers should make prior arrangements with experts.
6. Communication of the incidental finding Policies for the communication of the incidental finding to the research participant should
align with national regulations and customs.
7. Further clinical management and follow-up
of the research participant
In case of serious incidental findings, researchers should take responsibility for the clinical
follow-up of the research participant (i.e. through adequate and timely referral).
Researchers should make prior arrangements with relevant clinicians.
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Anticipation of findings
There is an increasing body of literature showing that
incidental findings can and should be anticipated
[10, 19, 26, 39]. Researchers who are involved in set-
ting up an imaging study should acknowledge that
incidental findings may occur. Researchers should assess
the type and the frequency of findings to be expected, based
on the type of scans that will be acquired and the study
population. For large-scale studies in which diagnostic-
quality scans are acquired, it is considered best practice to
determine, prior to the start of the study, which (types of)
findings, if detected, will or will not be reported. Represen-
tatives of large population-based studies who attended our
expert meeting recounted that their respective research
groups had agreed upon a list of findings to be reported
and a list of findings not to be reported. They had estab-
lished multidisciplinary panels, in which radiologists and
clinicians worked together to develop such lists. Some
studies have used the Rotterdam Study protocol for the
handling of incidental findings [40], which contains a
list for brain MRI, as a model. In drawing up a list of
anticipated incidental findings to be reported, the clin-
ical validity and utility of the findings [23] should be
central criteria. This does not imply that information
should only be returned if it pertains to diseases that
can effectively be treated.
There are limits to the utility of lists: not all incidental
findings can or need be anticipated. Attendants at our
expert meeting reported that incidental findings that are
not anticipated - and therefore not included in lists - are
discussed on a case-by-case basis in multidisciplinary
panels. Also, such panels serve to evaluate and revise the
lists over time, as experience with incidental findings
accumulates within studies.
Information provision and informed consent
It is generally agreed upon that as part of the informed
consent process, research participants should be informed
about the possibility that incidental findings can be de-
tected and about the study’s pathway for the handling of
incidental findings [26], including when and how research
participants will be informed about an incidental finding,
if detected. Ideally, research participants should be given
the opportunity to consent to research participation
while opting out of receiving information about inci-
dental findings [19, 35, 36, 41]. Allowing participants to
opt out helps to avoid unnecessary pressure to learn
about - possibly unwanted - health-related information.
Researchers or ethics committees may wish to qualify
such an opt-out option, so that, if feedback of an inci-
dental finding were necessary to prevent serious harm
to the research participant [42], an exception could be
made and the finding could be reported anyway. This
option is called a ‘conditional opt-out’ option. Experts
who attended our meeting indicated that generally only
a small minority of research participants chooses to opt
out of receiving information about incidental findings,
and reported that it should be feasible to check the in-
formed consent form first for research participants’
stated preferences, before contacting them.
Scan acquisition
Researchers must inevitably decide in advance which
sequences will be acquired during the study. Current
guidance suggests that researchers are not required to
make any additional scans for the purposes of increasing
the likelihood of detecting incidental findings [26]. Thus,
the scanning protocols should simply be the minimum
required to answer the research question [22]. This im-
plies that researchers can perfectly well acquire scans of
(very) limited diagnostic utility only. This was corrob-
orated in our expert meeting. Further, radiographers
or researchers who are performing the scans should be
instructed whether or not to review scans during scan
acquisition, and to what degree, for the presence of
abnormalities. It should be clear to radiographers or
researchers who are performing the scans, what is ex-
pected of them during scan acquisition.
Review of scans
Traditionally, there has not been any moral obligation
for researchers to ‘hunt’ or actively look for incidental
findings when conducting research [26, 34]. Many re-
spondents within our interview study did not support a
duty to look for abnormalities. By contrast, however,
attendants at our expert meeting agreed that it is currently
best practice to arrange some form of routine review of
research scans. The NIH, for instance, requires that on its
campuses, all research scans are “examined by a qualified
and experienced member of the research team” [43]. Also
the UK Medical Devices Agency (MDA) recommends that
all volunteer MRI examinations are routinely reported by a
radiologist [18]. The international Mind Research Network
provides routine review for its members by contracted
board-certified neuroradiologists [44]. Some studies make
use of a two-step approach to routine review of scans,
including a first step in which trained researchers (radi-
ologists in training) review scans for abnormalities, and
a second step in which an expert radiologist clinically
reviews suspect scans [29]. Though for some research
centres, especially those that are not hospital-based or
hospital-affiliated, it may be logistically and/or finan-
cially difficult to arrange routine review of scans, the
costs need not be prohibitive [44]. Further, when scans
acquired are not of diagnostic quality (e.g. fMRI scans),
routine review may not be feasible or valuable. How-
ever, in large imaging studies in which diagnostic-
quality scans are acquired, some form of routine review
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should be performed [29]. This recommendation was
corroborated in our expert meeting. This implies that
in some research settings, researchers may be expected
to actively look for abnormalities, which raises ques-
tions about a ‘duty to hunt’ incidental findings.
Consultation on detected abnormalities
When an abnormality is detected, the research scan
should be assessed by an expert [19], usually a radiologist.
The radiologist is consulted first to verify that an abnormal-
ity is indeed present on the scan and to provide a diagnosis.
Then, the radiologist will have to determine whether or not
the abnormality is of clinical relevance to the research par-
ticipant, and whether or not it should be reported to the
research participant. This judgment should preferably be
made not by the radiologist alone, but in consultation with
a relevant clinician. When a list of findings (not) to report
has previously been established (in collaboration with rele-
vant clinicians), this list can serve as a basis for the radiolo-
gist’s judgment of clinical significance. To many ethics
committees, confirmation by an expert radiologist is an
explicit requirement for any feedback of incidental findings
to research participants [45]. This requirement is applicable
to all research contexts, and implies that even for small-
scale scan studies, research teams should establish contact
with a radiologist who can be consulted in case of a pre-
sumed abnormality. A pathway for consultation needs to be
in place prior to the start of the study.
Communication of the incidental finding
In some countries, the communication of a clinically
relevant incidental finding to a research participant must
legally be undertaken by a licensed physician. In these
countries, one or more physicians should preferably be
part of the research team of large-scale imaging studies,
in which incidental findings are expected to occur
frequently. In small-scale studies or in studies in which
only sequences lacking diagnostic utility are acquired, it
may suffice for the research team to make prior arrange-
ments with regional primary care physicians or medical
specialists, who can be called upon in case an incidental
finding is detected. The feedback of incidental findings
will then take place via the primary care physician or
general practitioner of the research participant [19, 46].
In other jurisdictions, researchers (who are not physi-
cians) may report their findings directly to research par-
ticipants and advise them to consult with a primary care
physician or a medical specialist. Some of our respon-
dents felt that it would violate the privacy rights of the
research participant to ‘go behind their backs’ and
inform their primary care physicians without informing
them first. This has been suggested in other studies, too
[1]. Experts attending our meeting stated that therefore,
in their studies, research participants are contacted directly
and verbally (over the phone) by a physician who is part of
the research team. In some countries, other experts in-
dicated, a written letter would be the customary man-
ner in which first contact is made with the research
participant about the incidental finding. Most atten-
dants agreed that although serious findings should
preferably be discussed face-to-face with the research
participant [36], in their experience, it is possible to
discuss incidental findings adequately over the course of
one or more phone calls, provided that follow-up clinical
care is offered in a timely manner.
Further clinical management and follow-up of the research
participant
Attendants at our expert meeting agreed that researchers
should take responsibility for the follow-up of the research
participant. They are expected to prevent or minimize
harm in research participants, but should also show respect
for research participants [46]. Moreover, they should pro-
vide the ancillary care of returning clinically relevant inci-
dental findings [34]. It can be argued that a certain degree
of care entails that researchers cannot merely inform re-
search participants about a potentially significant finding,
they must also support them in addressing that finding. As
researchers themselves may not be in the position to ad-
dress the finding, they should help research participants
find physicians who can. At minimum, researchers must
refer the research participant to a relevant clinician, and
must make the research scan and/or the radiologist’s report
available. Ideally, the research team will have made prior
arrangements with relevant clinicians in an associated
hospital or elsewhere in the region, such that, whenever an
incidental finding is detected, the research participant can
be seen in a matter of days. Especially when the finding is
serious and/or requires urgent medical attention, clinical
follow-up should be available to research participants in a
timely manner. The research team should preferably ar-
range some form of evaluation of the clinical follow-up of
research participants, with the aim of further improving the
pathway for the handling of incidental findings.
The seven steps described above will interact with one
another. For example, the type of scans acquired (i.e.
diagnostic-quality or not) will influence the likelihood
that clinically relevant incidental findings are detected
and therewith, will determine whether or not it is sens-
ible to arrange routine clinical review of research scans.
In studies in which diagnostic-quality scans are made,
much more demanding pathways for the handling of in-
cidental findings will be required than in studies in
which sequences are acquired of limited diagnostic util-
ity. After all, in the former, incidental findings will be
frequent and interpretable, and, when clinically relevant,
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will require action on the part of the researcher. The line
of action to be undertaken by researchers who acquire
diagnostic-quality research scans, should be carefully
anticipated, agreed upon, and assessed by an ethics re-
view committee. Researchers and ethics review commit-
tees should increase their focus on the careful handling
of incidental findings detected through imaging in re-
search, so that ad hoc decision-making can be avoided
and that research participants can know, in advance,
what to expect with regard to incidental findings.
Conclusion
This paper presents an ethical framework consisting of
seven steps, in which researchers should make decisions
about the design of a pathway for the handling of incidental
findings prior to the start of their imaging study. Given the
variability among research settings, the framework does not
prescribe how - or what - decisions should be made.
The framework does point out that - and where - decisions
must be made, and requires researchers to justify these
decisions based not only on cost and feasibility consider-
ations, but also on current best practices and research
participants’ moral expectations.
Ethics review committees have the important task of
evaluating pathways for the detection, management and
communication of incidental findings within imaging
studies. Whereas, as of yet, ethics committees have com-
monly required that a pathway be in place for the hand-
ling of incidental findings, they have not always specified
what that pathway should look like. With this framework
and the considerations offered in this paper, we aim at
assisting ethics committees in the assessment of the
appropriateness of proposed pathways. The development
of consistent, transparent and appropriate pathways will
be indispensable to maintain public trust in the coming
years, as research imaging will affect thousands of
research participants worldwide. In research contexts in
which diagnostic-quality scans are acquired, appropriate
pathways for the handling of incidental finding will re-
quire additional effort, funding and care on the part of
the researchers. This additional effort, however, is not a
reason to neglect incidental findings. Rather, it is neces-
sary to meet the principle of reciprocity, as it is part of
researchers’ responsibilities to protect the interests of
research participants.
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